XML 55 R39.htm IDEA: XBRL DOCUMENT v3.22.1
Collaboration Agreements And Business Development Activities - GSK Narrative (Details) - USD ($)
$ in Millions
3 Months Ended
Apr. 01, 2022
Apr. 02, 2021
Collaboration Agreement with GlaxoSmithKline    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Percent of royalty on net sale 3.00%  
Royal Pharma    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Royalty expense $ 13.1 $ 10.1